\
&
Contact us
\
&
Contact us
This was 1 year ago
Locationonline
ProgrammesWebinar in anticipation of the Call for Proposals for a new KIC in the water, marine and maritime sectors and ecosystems.
During this third webinar participants will learn about the EIT Funding model and how financial sustainability is at the core of the EIT model.
EIT will then dive deeper into the EIT and KIC (Knowledge & Innovation Community) Governance and the EIT Grant Lifecycle and the contractual relationships between the EIT and the KIC.
Finally, there will be a presentation on the monitoring and evaluation instruments that the EIT uses.
More information - here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
